Physician profile
Samuel E Donofrio
NPI 1912951658
$2,704.55
in general payments reported to CMS, 2019-2025
16 companies · $581 in 2025
The $581 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $122 · 2021: $280 · 2022: $432 · 2023: $581 · 2024: $367 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,529.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $495.32 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Allergan, INC. | $385.60 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $324.15 | 2020-2023 | |
| Alcon Vision LLC | $259.49 | 2019-2025 | Precision7, Precision 1 |
| Coopervision INC. | $254.33 | 2022-2024 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Abbvie INC. | $247.54 | 2022-2024 | Lumigan, Alphagan P, Vuity |
| Sun Pharmaceutical Industries INC. | $170.44 | 2019-2023 | Cequa |
| Oyster Point Pharma, INC. | $160.35 | 2022-2024 | Tyrvaya |
| Johnson & Johnson Vision Care, INC. | $126.35 | 2019-2023 | Acuvue |
| Optos, INC. | $97.88 | 2020-2025 | |
| Biotissue Holdings INC. | $76.10 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $28.43 | 2019-2021 | |
| Harrow Eye, LLC | $24.39 | 2024 | Vevye |
| Alcon Research LLC | $21.89 | 2019 | |
| Shire North American Group INC | $16.32 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $15.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Donofrio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.